Different from other IR indices such as the homeostasis model assessment of insulin resistance (HOMA-IR) index, quantitative insulin sensitivity check index (QUICKI), and homeostasis model assessment of β-cell function (HOMA-β), TyG does not require insulin quantification and may be more useful to evaluate IR for T2DM patients regardless of insulin treatment. This evidence concerns the gene INS and type 2 diabetes mellitus.